Jeffrey S. Barrett
Jeffrey S. Barrett
Chief Science Officer, Aridhia Bioinformatics
Verified email at
Cited by
Cited by
Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism
S Murin, PS Romano, RH White
Thrombosis and haemostasis 88 (09), 407-414, 2002
Shortening the timeline of pediatric phase I trials: the rolling six design
JM Skolnik, JS Barrett, B Jayaraman, D Patel, PC Adamson
Journal of Clinical Oncology 26 (2), 190-195, 2008
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.
K Peerlinck, I De Lepeleire, M Goldberg, D Farrell, J Barrett, E Hand, ...
Circulation 88 (4), 1512-1517, 1993
Population pharmacokinetic studies in pediatrics: issues in design and analysis
B Meibohm, S Lšer, JC Panetta, JS Barrett
The AAPS journal 7, E475-E487, 2005
Physiologically based pharmacokinetic (PBPK) modeling in children
JS Barrett, O Della Casa Alberighi, S Lšer, B Meibohm
Clinical Pharmacology & Therapeutics 92 (1), 40-49, 2012
Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men
JS Barrett, G Murphy, K Peerlinck, ID Lepeleire, RJ Gould, D Panebianco, ...
Clinical Pharmacology & Therapeutics 56 (4), 377-388, 1994
Population pharmacokinetics of fluconazole in young infants
KC Wade, D Wu, DA Kaufman, RM Ward, DK Benjamin Jr, JE Sullivan, ...
Antimicrobial agents and chemotherapy 52 (11), 4043-4049, 2008
Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings
JS Barrett, MJ Fossler, KD Cadieu, MR Gastonguay
The Journal of Clinical Pharmacology 48 (5), 632-649, 2008
Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization
JS McCune, MJ Bemer, JS Barrett, K Scott Baker, AS Gamis, NHG Holford
Clinical Cancer Research 20 (3), 754-763, 2014
Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor
SA Mousa, S Mohamed
Thrombosis and haemostasis 92 (09), 627-633, 2004
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function
I Mahť, M Aghassarian, L Drouet, K Lacut, JJ Heilmann, D Mottier, ...
Thrombosis and haemostasis 97 (04), 581-586, 2007
Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
X Zuo, CM Ng, JS Barrett, A Luo, B Zhang, C Deng, L Xi, K Cheng, Y Ming, ...
Pharmacogenetics and genomics 23 (5), 251-261, 2013
Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6
BJ Gertz, JS Barrett, R Eisenhandler, DA Krupa, JM Wittreich, JR Seibold, ...
The Journal of Clinical Endocrinology & Metabolism 77 (5), 1393-1397, 1993
Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications
HJ Pieniaszek Jr, M Mayersohn, MP Adams, RJ Reinhart, JS Barrett
The Journal of Clinical Pharmacology 39 (8), 817-825, 1999
Population pharmacokinetics and pharmacodynamics of ciclesonide
S Rohatagi, V Arya, K Zech, R Nave, G Hochhaus, BK Jensen, JS Barrett
The Journal of Clinical Pharmacology 43 (4), 365-378, 2003
A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms
A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ...
The AAPS journal 15, 1072-1081, 2013
Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography–electrospray ionization mass spectrometry
JI Lee, M Narayan, JS Barrett
Journal of Chromatography B 845 (1), 95-103, 2007
Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography–electrospray tandem mass spectrometry
JI Lee, BH Hsu, D Wu, JS Barrett
Journal of Chromatography A 1116 (1-2), 57-68, 2006
Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study
JW Hainer, JS Barrett, CA Assaid, MJ Fossler, DS Cox, T Leathers, ...
Thrombosis and haemostasis 87 (05), 817-823, 2002
A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam
AR Maharaj, JS Barrett, AN Edginton
The AAPS journal 15, 455-464, 2013
The system can't perform the operation now. Try again later.
Articles 1–20